home / stock / bpts / bpts news

BPTS News and Press, Biophytis SA From 04/05/22

Stock Information
Company Name: Biophytis SA
Stock Symbol: BPTS
Market: NASDAQ
Menu
BPTS BPTS Quote BPTS Short BPTS News BPTS Articles BPTS Message Board
Get BPTS Alerts

News, Short Squeeze, Breakout and More Instantly...
BPTS - Biophytis Appoints Philippe Rousseau as Chief Financial Officer

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 5, 2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company specialized in the development of therapeutics that slow the degenerative processes associated with ag...
BPTS - VTNR, TKAT and ISIG among mid-day movers

Gainers: Protalix BioTherapeutics (PLX) +74%. Aterian (ATER) +62%. Dingdong Limited (DDL) +40%. Jumia Technologies (JMIA) +30%. Twitter (TWTR) +27%. Takung Art (TKAT) +24%. Gracell Biotechnologies (GRCL) +22%. Cognition Therapeutics (CGTX) +21%. Poema Global Holdings (PPGH) +20%. Biophytis (B...

BPTS - Protalix, Biophytis top healthcare gainers; while Curis, Longeveron lead losers' pack

Gainers: Protalix BioTherapeutics (PLX) +70%. Biophytis (BPTS) +21%. Clovis Oncology (CLVS) +13%. IN8bio (INAB) +13%. Acer Therapeutics (ACER) +12%. Losers: Curis (CRIS) -39%. Longeveron (LGVN) -15%. Bioventus (BVS) -14%. Clever Leaves (CLVR) -8%. NanoV...

BPTS - Biophytis will Participate in a Key Workshop on Functional Limitations for the Elderly

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 16,2022 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "company") a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging,...
BPTS - Clover Health, Monte Rosa top healthcare gainers; Atreca, Biophytis lead losers' pack

Gainers: Clover Health Investments (NASDAQ:CLOV) +18%. Monte Rosa Therapeutics (NASDAQ:GLUE) +12%. Sharecare (NASDAQ:SHCR) +10%. InflaRx (NASDAQ:IFRX) +9%. Sigilon Therapeutics (NASDAQ:SGTX) +9%. Losers: Atreca (NASDAQ:BCEL) -30%. Biophytis (NASDAQ:BPTS) -14%. Alpine Immun...

BPTS - BioCardia, Biophytis top healthcare gainers; Kiromic, Mainz Biomed among losers

Gainers: BioCardia BCDA +32%. Biophytis BPTS +17%. Mersana Therapeutics MRSN +7%. Liquidia (NASDAQ:LQDA) +5%. Vaccitech (NASDAQ:VACC) +3%. Losers: Kiromic BioPharma KRBP -17%. Mainz Biomed (NASDAQ:MYNZ) -9%. Vaccinex (NASDAQ:VCNX) -7%. NeuroBo Phar...

BPTS - AUR, MRSN and BCDA among pre market gainers

BioCardia (NASDAQ:BCDA) +32% receives FDA breakthrough device designation for CardiAMP cell therapy system for heart failure. Bon Natural Life (NASDAQ:BON) +29% on FY results. Lightning eMotors (NYSE:ZEV) +19% after electrification deal with General Motors. Redwire (NYSE:RDW) +...
BPTS - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re starting off another day of trading with a breakdown of the biggest pre-market stock movers for Thursday! Source: Shutterstock There’s plenty of earnings news, as well as up...

BPTS - Biophytis to treat severe COVID-19 patients with Sarconeos in Brazil under EAP

Biophytis (NASDAQ:BPTS) soars 21.5% premarket after receiving approval from the ANVISA (Brazilian health authority) for its Expanded Access Program (EAP) to treat hospitalized patients with severe COVID-19 with Sarconeos (BIO101). A maximum of 80 patients who are mechanically ventil...

BPTS - Biophytis Received Approval from ANVISA (Brazil) to Give Access to Sarconeos (BIO101) to Hospitalized COVID-19 Patients through an Expanded Access Program

ANVISA (Brazilian Health Authority) approved Biophytis' Expanded Access Program (EAP) for hospitalized patients with severe COVID-19 and mechanically ventilated in Intensive Care Unit Sarconeos (BIO101) treatment will be given to a maximum of 80 patients mechanically ventilated in Inte...
Previous 10 Next 10